Abstract Background Transcatheter valve-in-valve replacement (TMViVR) is an alternative option for patients with bioprosthetic valve failure (BVF) who are at
Transcatheter heart valves technologies
Transcatheter heart valves technologies
Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis
Abstract Background Patients with active cancer and aortic stenosis may be under-referred for valve interventions due to concerns over a
Transcatheter heart valves technologies
Weekend effect on in-hospital outcomes of transcatheter aortic valve replacement: insights from a propensity-matched national analysis
Abstract Background The “weekend effect” on hospital admissions has been extensively studied, showing increased risks for patients admitted on weekends
Transcatheter heart valves technologies
Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: an updated systematic review and meta-analysis
Abstract Clinical outcomes for TAVR in cancer survivors with prior chest radiation therapy (C-XRT) who develop symptomatic aortic-valve stenosis are
Transcatheter heart valves technologies
Management of Acute Coronary Syndrome in Patients With Transcatheter Aortic Valve Replacement: A Review
Abstract Transcatheter aortic valve replacement (TAVR) has become a viable treatment option for patients with severe aortic stenosis among all
Transcatheter heart valves technologies
Recurrent strokes after transcatheter aortic valve replacement in an elderly patient with severe bicuspid aortic valve stenosis: a case report
Abstract Background Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients
Transcatheter heart valves technologies
Anatomy of Risk: Decoding the Predictors of Vascular Access Complications in Transcatheter Aortic Valve Replacement
Abstract Background Despite advancements in valve implantation devices, vascular access complications (VAC) remain a significant cause of morbidity and mortality
Transcatheter heart valves technologies
Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation
Abstract Introduction Direct oral anticoagulant (DOAC) dose adjustment is based on age, renal function, and body weight. There is a
Transcatheter heart valves technologies
Transcatheter Aortic Valve Replacement: Full Unilateral Access Using the Ipsilateral Superficial Femoral Artery Is Effective
Abstract Background Access site complications are very common complications in transcatheter aortic valve replacement (TAVR). Usually, a second arterial sheath
